We sat down for a Q&A with investors in a conversation moderated by Shareholder Nathan Reese.


Predictive Oncology
Proactive interview focuses on new category of oncology drug discovery
Predictive Oncology CEO Raymond Vennare and Dr. Robert Murphy, an inventor of the engine behind our artificial intelligence (AI) platform and new member of our